Esperion Therapeutics
ESPR
#7608
Rank
S$0.39 B
Marketcap
$2.01
Share price
-6.83%
Change (1 day)
-44.34%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$3.85

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.79. In 2022 the company made an earnings per share (EPS) of -$4.77 an increase over its 2021 EPS that were of -$12.83.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.85-19.19%
2022-$4.77-62.87%
2021-$12.8380.38%
2020-$7.1150.14%
2019-$4.74-53.18%
2018-$10.127.41%
2017-$9.42110.81%
2016-$4.4747.35%
2015-$3.030.89%
2014-$3.0128.84%
2013-$2.33-89.3%
2012-$21.82
2002-$9.198.89%
2001-$8.44-83.77%
2000-$52.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.75 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.05-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.50-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$50.15-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.86-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.91-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA